Background: Asthma and obesity are associated disorders, but the contribution of obesity to
difficult‐to‐treat asthma as well as the mechanisms responsible for this relationship are …

Alveolar nitric oxide (NO) is a measure of peripheral airway inflammation in asthma,
potentially associated with disease severity. The relationship between alveolar NO and …

A subset of patients with asthma is known to have progressive loss of lung function despite
treatment with corticosteroids. The aim of the present study was to identify risk factors of …

In 1998 and 1999 (visit 1), patient characteristics (sex, age, atopic status, asthma onset and
duration, medication use), prebronchodilator and postbronchodilator FEV1, bronchial …

… van Veen received payment from AstraZeneca and Sanofi Genzyme. None of the other …
en behandeling van specifieke groepen astmapatiënten/Utility of FeNO in diagnosis and …

Background In patients with prednisone-dependent asthma the dose of oral corticosteroids
should be adjusted to the lowest possible level to reduce long-term adverse effects. However…

… van Bezouw PhD n , Marjo J… van de Ven MD, PhD m , Anneke van Veen MD, PhD o , Edwin
van Velzen MD, PhD p , Ilonka HPAA van Veen MD, PhD g … Elisabeth H. Bel MD, PhD a c …

… MD, PhD f , Frank WJM Smeenk MD, PhD g , Ilonka HPAA van Veen MD, PhD h , Els JM
Weersink MD, PhD i , Karin B. Fieten MSc, PhD j , Simone Hashimoto MD, PhD i , Anneke …

Background Many patients with severe asthma are overweight or obese, often attributed to
unintentional weight gain as a side effect of oral corticosteroids (OCSs). Anti–IL-5/5Ra …

… van Veen a , A. ten Brinke b , AC van der Linden a , KF Rabe a , EH Bel a … van Veen is
supported by an unrestricted educational grant from Astra Zeneca. …